Hood River Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Buy
1,056,871
+368,317
+53% +$44.6M 0.82% 34
2026
Q1
$113M Buy
688,554
+50,977
+8% +$7.84M 1.13% 22
2025
Q4
$111M Sell
637,577
-243,826
-28% -$44.5M 1.22% 22
2025
Q3
$127M Sell
881,403
-18,200
-2% -$2.23M 1.5% 15
2025
Q2
$90.5M Sell
899,603
-658,683
-42% -$50.4M 1.26% 22
2025
Q1
$119M Buy
1,558,286
+32,658
+2% +$2.5M 2.03% 5
2024
Q4
$105M Buy
1,525,628
+53,073
+4% +$3.82M 1.56% 10
2024
Q3
$107M Buy
1,472,555
+157,163
+12% +$11.6M 1.74% 12
2024
Q2
$88.1M Buy
1,315,392
+352,891
+37% +$13.7M 1.83% 11
2024
Q1
$26.1M Buy
962,501
+56,682
+6% +$1.59M 0.58% 61
2023
Q4
$28.1M Buy
+905,819
New +$23.5M 0.77% 53
2022
Q2
Sell
-449,595
Closed -$10.6M 128
2022
Q1
$10.6M Buy
449,595
+459
+0.1% +$10.7K 0.35% 76
2021
Q4
$12.2M Buy
449,136
+35
+0% +$1K 0.37% 74
2021
Q3
$12.4M Sell
449,101
-17,326
-4% -$455K 0.38% 74
2021
Q2
$13.3M Sell
466,427
-6,800
-1% -$202K 0.4% 81
2021
Q1
$16.1M Sell
473,227
-48,329
-9% -$1.85M 0.52% 76
2020
Q4
$17.4M Buy
+521,556
New +$19.1M 0.57% 72

Other funds holding INSM

Hood River Capital Management's INSM Position: Q2 2026 in Review

Hood River Capital Management increased its Insmed (INSM) stake by 53% in Q2 2026, buying an estimated $44.6M and bringing the position to 1,056,871 shares worth $113M. The position accounts for 0.82% of the portfolio, ranked #34.

Hood River Capital Management first reported a position in INSM in Q4 2020 and has held it in 17 quarters since. The position peaked at $127M in Q3 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Hood River Capital Management held 1,056,871 shares of Insmed worth $113M as of Q2 2026.
  • Hood River Capital Management bought 368,317 Insmed shares in Q2 2026, an estimated $44.6M.
  • Insmed made up 0.82% of Hood River Capital Management's portfolio in Q2 2026, its #34 holding.
  • Hood River Capital Management first reported a position in Insmed in Q4 2020 and has held it in 17 quarters since.
  • Hood River Capital Management's Insmed position peaked at $127M in Q3 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.